Database Entry Point
max planck institut
informatik
mpii logo Minerva of the Max Planck Society
 

D3 INF Publications, generated: 23:16, 9 February 2010

Search the publication database

  . Return

Your search returned the following 23 documents:

  1. Kirsten Roomp, Niko Beerenwinkel, Tobias Sing, Eugen Schülter, Joachim Büch, Saleta Sierra-Aragon, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Thomas Lengauer, and Joachim Selbig
    Arevir: A Secure Platform for Designing Personalized Antiretroviral Therapies Against HIV
    Lecture Notes in Computer Science 4075: 185-194, 2006
  2. Jens Verheyen, Elena Litau, Tobias Sing, Martin Däumer, Melanie Balduin, Mark Oette, Gerd Fätkenheuer, Jürgen K. Rockstroh, Ulrike Schuldenzucker, Daniel Hoffmann, Herbert Pfister, and Rolf Kaiser
    Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients
    Antiviral Therapy 11 (7): 879-887, 2006
  3. Tobias Sing, Valentina Svicher, Niko Beerenwinkel, Francesca Ceccherini-Silberstein, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, Mark Oette, Jürgen K. Rockstroh, Gerd Fätkenheuer, Carlo-Federico Perno, and Thomas Lengauer
    Characterization of novel HIV Drug Resistance Mutations using clustering, multidimensional scaling and SVM-based feature ranking
    In: Knowledge Discovery in Databases: PKDD 2005., Porto, Portugal, 2005, 285-296
  4. Niko Beerenwinkel, Tobias Sing, Thomas Lengauer, Jörg Rahnenführer, Kirsten Roomp, Igor Savenkov, Roman Fischer, Daniel Hoffmann, Joachim Selbig, Klaus Korn, Hauke Walter, Thomas Berg, Patrick Braun, Gerd Fätkenheuer, Mark Oette, Jürgen Rockstroh, Bernd Kupfer, Rolf Kaiser, and Martin Däumer
    Computational methods for the design of effective therapies against drug resistant HIV strains
    Bioinformatics 21 (21): 3943-3950, 2005
  5. Niko Beerenwinkel, Martin Däumer, Tobias Sing, Jörg Rahnenführer, Thomas Lengauer, Joachim Selbig, Daniel Hoffmann, and Rolf Kaiser
    Estimating HIV evolutionary pathways and the genetic barrier to drug resistance
    The Journal of Infectious Diseases 191 (11): 1953-1960, 2005
  6. Melanie Balduin, Niko Beerenwinkel, Saleta Sierra, Martin Däumer, Jürgen Rockstroh, Mark Oette, Gerd Fätkenheuer, Bernd Kupfer, Daniel Hoffmann, Joachim Selbig, Herbert Pfister, and Rolf Kaiser
    Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy
    J Clin Virol 34 (4): 277-287, 2005
  7. Tobias Sing, Niko Beerenwinkel, Rolf Kaiser, Daniel Hoffmann, Martin Däumer, and Thomas Lengauer
    Geno2pheno[coreceptor]: a tool for predicting coreceptor usage from genotype and for monitoring coreceptor-associated sequence alterations
    In: Proceedings of the 3rd European HIV Drug Resistance Workshop, Athens, Greece, 2005
  8. Niko Beerenwinkel, Jörg Rahnenführer, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Joachim Selbig, and Thomas Lengauer
    Learning multiple evolutionary pathways from cross-sectional data
    Journal of Computational Biology 12 (6): 584-598, 2005
  9. Niko Beerenwinkel, Jörg Rahnenführer, Rolf Kaiser, Daniel Hoffmann, Joachim Selbig, and Thomas Lengauer
    Mtreemix: a software package for learning and using mixture models of mutagenetic trees
    Bioinformatics 21 (9): 2106-2107, 2005
  10. Niko Beerenwinkel, Jörg Rahnenführer, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Joachim Selbig, and Thomas Lengauer
    Learning multiple evolutionary pathways from cross-sectional data
    In: RECOMB 2004 : proceedings of the Eighth Annual International Conference on Research in Computational Molecular Biology, San Diego, USA, March, 27-31, 2004, 36-44
  11. Niko Beerenwinkel, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Joachim Selbig, and Thomas Lengauer
    Bioinformatikmethoden für die Optimierung antiviraler Kombinationstherapien
    In: MPG Jahrbuch, 2003, 481-486
  12. Niko Beerenwinkel, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, Joachim Selbig, and Thomas Lengauer
    Estimating effective drug combinations against drug-resistant mutants from genotypes
    In: Proceedings of the 1st European HIV Drug Resistamce Workshop, Luxembourg, March 6-8, 2003, 2003, 18-18
  13. Niko Beerenwinkel, Martin Däumer, Mark Oette, Klaus Korn, Daniel Hoffmann, Rolf Kaiser, Thomas Lengauer, Joachim Selbig, and Hauke Walter
    Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes
    Nucleic Acids Research 31 (13): 3850-3855, 2003
  14. Niko Beerenwinkel, Thomas Lengauer, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, and Joachim Selbig
    Methods for optimizing antiviral combination therapies
    Bioinformatics 19 (Supplement): i16-i25, 2003
  15. Mario Albrecht, Daniel Hoffmann, Bernd O. Evert, Ina Schmitt, Ullrich Wüllner, and Thomas Lengauer
    Structural modeling of ataxin-3 reveals distant homology to adaptins
    Proteins: Structure, Function, and Genetics 50 (2): 355-370, 2003
  16. Katharina Wolf, Hauke Walter, Niko Beerenwinkel, Wilco Keulen, Rolf Kaiser, Daniel Hoffmann, Thomas Lengauer, Joachim Selbig, Anne-Mieke Vandamme, Klaus Korn, and Barbara Schmidt
    Tenofovir resistance and resensitization
    Antimicrobial Agents and Chemotherapy 47 (11): 3478-3484, 2003
  17. Niko Beerenwinkel, Rolf Kaiser, Jörg Rahnenführer, Martin Däumer, Daniel Hoffmann, Joachim Selbig, and Thomas Lengauer
    Tree models for the evolution of drug resistance
    In: XII International HIV Drug resistance Workshop, Los Cabos, Mexico, June 10 - June 14, 2003, S107-S107
  18. Daniel Hoffmann, Volker Schnaible, Stephan, Wefing, Mario Albrecht, Daniel Hanisch, and Ralf Zimmer
    A new method for the fast solution of protein-3D-structures, combining experiments and bioinformatics
    In: Coupling of Biological and Electronic Systems: Proceedings of the 2nd Caesarium, Bonn, 1-3 November 2000, Bonn, Germany, 2002, 59-78
  19. Niko Beerenwinkel, Barbara Schmidt, Hauke Walter, Rolf Kaiser, Thomas Lengauer, Daniel Hoffmann, Klaus Korn, and Joachim Selbig
    Diversity and complexity of HIV-1drug resistance: A bioinformatics approach to predicting phenotype from genotype
    Proceedings of the National Academy of Sciences 99 (12): 8271-8276, 2002
  20. Niko Beerenwinkel, Thomas Lengauer, Martin Däumer, S. Sierra, Barbara Schmidt, Hauke Walter, Klaus Korn, Mark Oette, Gerd Fätkenheuer, J. Rockstroh, Daniel Hoffmann, Rolf Kaiser, and Joachim Selbig
    Geno2pheno is predictive of short-term virological response
    In: Proceedings from the 5th International Workshop on HIV Drug Resistance & Treatment Strategies, Scotsdale, Arizona, 2002, 74-74, paper no. 89.
  21. Niko Beerenwinkel, Thomas Lengauer, Barbara Schmidt, Hauke Walter, Rolf Kaiser, Daniel Hoffmann, Klaus Korn, and Joachim Selbig
    Quantitative phenotype prediction by support vector machines
    In: Proceedings from the 5th International Workshop on HIV Drug resistance & Treatment Strategies, Scotsdale, Arizona, 2002, 97 p.
  22. Niko Beerenwinkel, Barbara Schmidt, Hauke Walter, Rolf Kaiser, Thomas Lengauer, Daniel Hoffmann, Klaus Korn, and Joachim Selbig
    Geno2pheno: A system for the interpretation of genotypic HIV Drug resistance tests
    IEEE Intelligent Systems 16 (6): 35-41, 2001
  23. Niko Beerenwinkel, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Klaus Korn, Thomas Lengauer, Barbara Schmidt, Hauke Walter, and Joachim Selbig
    Neue Wege zur Optimierung von Anti-HIV Therapien
    BIOforum 24 (12): 912-914, 2001